Liver Cancer

Liver cancer is a malignant neoplastic disease of the liver. Hepatocellular carcinoma (HCC, also called hepatoma) is a primary malignancy (cancer) of the liver. Most cases are secondary to either hepatitis infection (usually hepatitis B or C) or cirrhosis (alcoholism being the most common cause of hepatic cirrhosis).

Liver Cancer - most related articles:

- Weight loss drug orlistat may lead to liver injury - 4.4
- Obesity enhances liver cancer risk - 4.3
- Hepatitis C declines health with liver disease - 4.2
- HIV positive have good survival rate after liver transplant - 3.9
- Incivek for hepatitis C infection is approved in US - 3.9
- Curcumin in turmeric may delay liver damage, cirrhosis - 3.7
- Low carbohydrate diet better than low calorie diet - 3.4
- Nexavar approved for patients with inoperable liver cancer - 3.3
- Hepatitis B hits men harder than women due to an abnormal protein - 3.1
- Acetaminophen not more than 325 mg in each dose - 3.1

Liver Cancer articles

Antibody may cure variety of human cancers
Human tumors transplanted into laboratory mice disappeared or shrank when scientists treated the animals with a single antibody. This antibody works by masking a protein flag on cancer cells that protects them from macrophages and other cells in the immune system.

Obesity enhances liver cancer risk
Epidemiological studies indicate that being overweight or obese is associated with increased cancer risk. The most dramatic effect of obesity on cancer risk has been noted for a common form of liver cancer called hepatocellular carcinoma or HCC.

New gene silencing way to turn off cervical cancer genes
Researchers at The University of Queensland have developed a way to deliver drugs which can specifically shut down cancer-causing genes in tumour cells while sparing normal healthy tissues.

Positive results of Albuferon in Chronic Hepatitis C
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that Albuferon (albinterferon alfa-2b) met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) in ACHIEVE 1, a Phase 3 clinical trial of Albuferon in combination with ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C (p=0.0008).

CyberKnife cancer robot in Harley Street Clinic and Apollo Hospitals
London's Harley Street Clinic, one of the UK's foremost centres for cancer medicine, has now taken delivery of the revolutionary CyberKnife cancer treatment machine – the first one of it kind in Britain.

Hepatitis C declines health with liver disease
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.

Short radiotherapy benefits breast cancer patients
A lower total dose of radiotherapy, delivered in fewer, larger treatments has been shown to be as effective as the international standard of a higher total dose delivered over a longer time to treat women with early breast cancer – according to new research published in the Lancet and Lancet Oncology today.

Middle class women earning more, drinking more
Middle-class women are drinking more alcohol than they realise because of larger wine glasses, and the more you earn, the more you drink - with those in higher income groups consuming 30 per cent more alcohol than the working classes.

New ultrasound technique sharpens view of liver tumors
A new high-energy form of ultrasound imaging developed by researchers at Duke University's Pratt School of Engineering produces pictures of liver tumors that are better than those made with traditional ultrasound, according to results of a clinical study.

Nexavar approved for patients with inoperable liver cancer
The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable. Nexavar was originally approved in 2005 for the treatment of patients with advanced renal cell carcinoma, a form of kidney cancer.

10 Liver Cancer articles listed above.

What is Liver Cancer
Liver cancer is a malignant neoplastic disease of the liver. Hepatocellular carcinoma (HCC, also called hepatoma) is a primary malignancy (cancer) of the liver. Most cases are secondary to either hepatitis infection (usually hepatitis B or C) or cirrhosis (alcoholism being the most common cause of hepatic cirrhosis).

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
1.98